AIDX
Financials
- Market Capitalization 6.05 M
- Employee 14
- Founded 2000
- CEO N/A
- Website www.2020biolabs.com
- Headquarter Delaware, United States
- FIGI BBG01ZZ5RSY3
- Industry Medical Devices
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 4889 |  NVNO enVVeno Medical Corporation - Common Stock | 11.03 USD | -3.08% | -9.44% | +7.93% | +155.32% | 7.36 M USD | ||
| 4915 |  SINT SiNtx Technologies, Inc. - Common Stock | 1.56 USD | -9.30% | -16.58% | -29.41% | -49.68% | 6.74 M USD | ||
| 4949 |  VVOS Vivos Therapeutics, Inc. - Common Stock | 0.42 USD | -2.33% | -12.50% | -25.00% | -93.93% | 5.84 M USD | ||
| 4963 |  INBS Intelligent Bio Solutions Inc. - Common Stock | 2.30 USD | +6.48% | +0.44% | -2.54% | -52.87% | 5.50 M USD |
Frequently asked questions about 20/20 Biolabs, Inc. - Common Stock
What is the 20/20 Biolabs, Inc. - Common Stock stock price today?
The current price of 20/20 Biolabs, Inc. - Common Stock (AIDX) is 0.57. Over the past 24 hours, the stock has changed by -3.39%. Follow the AIDX chart for real-time price dynamics.
What is the stock ticker of 20/20 Biolabs, Inc. - Common Stock?
20/20 Biolabs, Inc. - Common Stock trades under the ticker AIDX. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is 20/20 Biolabs, Inc. - Common Stock stock going up?
AIDX has changed by -5.00% over the last week, -26.92% over the last month, and -98.86% over the last year. Review the chart to see whether the current move is part of a broader trend.
What was 20/20 Biolabs, Inc. - Common Stock net income for the last quarter?
20/20 Biolabs, Inc. - Common Stock reported net income of -2.17 M for the last quarter. The previous quarter showed -815.6 K, which means net income changed by -166.65%.
How many employees does 20/20 Biolabs, Inc. - Common Stock have?
As of the latest available data, 20/20 Biolabs, Inc. - Common Stock has 14 employees. Workforce size can provide additional context about the company's scale and operations.
What is 20/20 Biolabs, Inc. - Common Stock EBITDA?
20/20 Biolabs, Inc. - Common Stock EBITDA is -1.43 M, and its EBITDA margin is -404.97%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy 20/20 Biolabs, Inc. - Common Stock stock?
You can buy 20/20 Biolabs, Inc. - Common Stock (AIDX) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in 20/20 Biolabs, Inc. - Common Stock stock?
Investing in 20/20 Biolabs, Inc. - Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the AIDX chart and related analysis on metatrader.com as part of your research.